Press releases 4 Mar 2026 Pandemic preparedness: Novo Nordisk Foundation renews its support to DNDi and THSTI to continue the development of broad-spectrum antivirals
Press Releases Translations 27 Feb 2026 L’acoziborole Winthrop, développé par DNDi et Sanofi, reçoit l’avis positif de l’Agence Européenne des Médicaments (EMA) en tant que traitement à dose unique à trois comprimés pour la forme la plus fréquente de la maladie du sommeil
Press releases 27 Feb 2026 Acoziborole Winthrop, developed by DNDi and Sanofi, receives European Medicines Agency positive opinion as three-tablet, single-dose treatment for most common form of sleeping sickness
In the media 27 Feb 2026 Maladie du sommeil : l’autorisation européenne d’un nouveau traitement laisse entrevoir une élimination de la maladie d’ici à 2030 Le Monde
In the media 27 Feb 2026 La maladie du sommeil bientôt éliminée ? Feu vert européen à un nouveau traitement France 24
In the media 27 Feb 2026 ‘Truly spectacular’ drug for sleeping sickness simplifies treatment, raising hopes for eradication Science
News 20 Feb 2026 DNDi welcomes GHIT support for lead identification of a novel chemical series in the Eisai-led Chagas disease project
Press releases 10 Feb 2026 DNDi and Dubai Health launch Middle East partnership to advance research and training in neglected diseases
Scientific articles 9 Feb 2026 Repurposing oxfendazole for onchocerciasis: Population pharmacokinetics of a tablet formulation in healthy African adults CPT: Pharmacometrics & Systems Pharmacology
Scientific articles 3 Feb 2026 Evaluation of quality of care in Chagas disease cardiomyopathy Global Heart
News 2 Feb 2026 Message on the passing of Professor Sir Nicholas White from DNDi Board Chair Dr Marie-Paule Kieny and DNDi Executive Director Dr Luis Pizarro
News 20 Feb 2026 DNDi welcomes GHIT support for lead identification of a novel chemical series in the Eisai-led Chagas disease project
News 2 Feb 2026 Message on the passing of Professor Sir Nicholas White from DNDi Board Chair Dr Marie-Paule Kieny and DNDi Executive Director Dr Luis Pizarro
News 30 Jan 2026 Imperial and DNDi strengthen partnership to accelerate treatments for neglected diseases
News 27 Jan 2026 DNDi and APHRC sign MoU to forge strategic alliance to bridge research and capacity enhancement gaps
News 4 Dec 2025 Dr Javid Abdelmoneim, Datuk Dr Mahathar bin Abd Wahab, Dr Taruna Madan, Violet Naanyu, and Dr Mario Santos Moreira join the Board of Directors at DNDi
News 26 Nov 2025 DNDi statement on the approval of the Instituto Butantan’s dengue vaccine and the need for a dengue treatment
News 17 Nov 2025 New DNDi report: Open science in a closed world – lessons and opportunities for securing openness and equitable access in R&D collaborations
News 3 Oct 2025 DNDi 2025 Projects of the Year recognize contributions of DNDi teams and partners working to deliver urgently needed innovations for people affected by Chagas disease and river blindness
News 8 Aug 2025 Statement from DNDi on Kenya’s elimination of rhodesiense sleeping sickness as a public health problem
